Total Payments
$1.0M
2024 Payments
$229,209
Companies
37
Transactions
1,362
Payment Breakdown by Category
Other$814,674 (80.1%)
Travel$118,682 (11.7%)
Consulting$61,756 (6.1%)
Food & Beverage$22,047 (2.2%)
Education$151.88 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $806,554 | 346 | 79.3% |
| Travel and Lodging | $118,682 | 412 | 11.7% |
| Consulting Fee | $61,756 | 25 | 6.1% |
| Food and Beverage | $22,047 | 571 | 2.2% |
| Honoraria | $8,121 | 4 | 0.8% |
| Education | $151.88 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $412,164 | 346 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $389,188 | 618 | $0 (2024) |
| ABBVIE INC. | $142,540 | 174 | $0 (2024) |
| Axsome Therapeutics, Inc. | $48,336 | 44 | $0 (2024) |
| Allergan, Inc. | $14,572 | 47 | $0 (2020) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $8,288 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $381.56 | 16 | $0 (2024) |
| Lundbeck LLC | $178.41 | 11 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $175.49 | 7 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $147.24 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229,209 | 259 | Neurocrine Biosciences, Inc. ($116,506) |
| 2023 | $262,639 | 260 | Neurocrine Biosciences, Inc. ($113,050) |
| 2022 | $201,621 | 222 | Neurocrine Biosciences, Inc. ($117,215) |
| 2021 | $121,031 | 176 | Neurocrine Biosciences, Inc. ($59,813) |
| 2020 | $43,031 | 105 | Otsuka America Pharmaceutical, Inc. ($26,799) |
| 2019 | $55,745 | 138 | Otsuka America Pharmaceutical, Inc. ($46,249) |
| 2018 | $49,591 | 84 | Otsuka America Pharmaceutical, Inc. ($49,555) |
| 2017 | $54,445 | 118 | Otsuka America Pharmaceutical, Inc. ($54,432) |
All Payment Transactions
1,362 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,106.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $88.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Travel and Lodging | In-kind items and services | $63.19 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | Cash or cash equivalent | $50.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | Cash or cash equivalent | $3.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,763.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $95.33 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: CNS | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,038.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $699.71 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $512.95 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $186.03 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $94.32 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
About Dr. Melissa Moody, M.D
Dr. Melissa Moody, M.D is a Psychiatry healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750505384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Moody, M.D has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $229,209 received in 2024. These payments were reported across 1,362 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($806,554).
Ad
Practice Information
- Specialty Psychiatry
- Location Charleston, WV
- Active Since 04/13/2007
- Last Updated 05/15/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750505384
Products in Payments
- INGREZZA (Drug) $412,164
- ABILIFY MAINTENA (Drug) $244,616
- VRAYLAR (Drug) $157,112
- REXULTI (Drug) $133,066
- Auvelity (Drug) $48,336
- ABILIFY ASIMTUFII (Drug) $10,225
- SPRAVATO (Drug) $146.55
- CAPLYTA (Drug) $141.42
- ARISTADA (Drug) $127.75
- LifeVest (Device) $127.47
- XARELTO (Drug) $121.91
- FANAPT (Drug) $114.91
- INVEGA SUSTENNA (Drug) $113.10
- TRINTELLIX (Drug) $106.62
- Austedo XR (Drug) $89.19
- XIFAXAN (Drug) $75.75
- Vascepa (Drug) $72.39
- Kerendia (Drug) $71.92
- SHINGRIX (Biological) $68.27
- Yupelri (Drug) $67.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Charleston
Ricardo Fermo, Md, MD
Psychiatry — Payments: $253,995
Psychiatry $253,995
Jacobo Mintzer, Md, MD
Psychiatry — Payments: $137,534
Psychiatry $137,534
James Ballenger, M.d, M.D
Psychiatry — Payments: $65,468
Psychiatry $65,468
Dr. Fahd Mousa, M.d, M.D
Psychiatry — Payments: $49,339
Psychiatry $49,339
Kathleen Brady, Md, MD
Psychiatry — Payments: $48,881
Psychiatry $48,881
Scott Christie, M.d, M.D
Psychiatry — Payments: $29,585
Psychiatry $29,585